IGF2BP3 and central nervous system cancer: Furthermore, the pan-cancer analysis demonstrated significant overexpression of IGF2BP3 in most cancer types (Fig. S1A), indicating its potential as a promising therapeutic target not only for glioma but also for other solid tumors.